SANUWAVE Health (NASDAQ:SNWV - Get Free Report) announced its earnings results on Friday. The company reported ($0.66) earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $9.34 million for the quarter.
SANUWAVE Health Stock Performance
Shares of SNWV stock traded up $2.41 during trading hours on Wednesday, reaching $35.67. 54,655 shares of the stock were exchanged, compared to its average volume of 30,578. SANUWAVE Health has a 12-month low of $5.17 and a 12-month high of $39.50. The firm has a market capitalization of $304.94 million, a price-to-earnings ratio of -7.82 and a beta of 1.25.
SANUWAVE Health Company Profile
(
Get Free Report)
SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.
Further Reading
Before you consider SANUWAVE Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SANUWAVE Health wasn't on the list.
While SANUWAVE Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
